Limited Cutaneous Systemic Sclerosis — Clinical Trials

MONDO:00163581 activeLast updated: Mar 20, 2026, 1:36 PM

Limited Cutaneous Systemic Sclerosis has an emerging clinical trial program, driven by drug treatment.

Recruiting

Active Trials

Drug Treatment1

Phase 2

Industry1

Galderma R&D

1 Trial

Phase 2Not Yet Recruiting

Sponsor:Galderma R&D

Started: Dec 2025Est. completion: Jul 2028Updated: Dec 2025

Stay informed about clinical trials for Limited Cutaneous Systemic Sclerosis.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 20, 2026 at 1:36 PM